Herclon (Trastuzumab Injection)
Herclon (Trastuzumab Injection) 440 Mg is a prescription drug for treatment of breast cancer. The generic name for the medicine is Trastuzumab.
Herceptin is approved for the treatment of early-stage breast cancer that is Human Epidermal growth factor Receptor 2-positive (HER2+) and has spread into the lymph nodes, or is HER2+ and has not spread into the lymph nodes. If it has not spread into the lymph nodes, the cancer needs to be estrogen receptor/progesterone receptor (ER/PR)-negative or have one high risk feature. Herceptin can be used in several different ways:
As part of a treatment course including the chemotherapy drugs Adriamycin (doxorubicin), Cytoxan (cyclophosphamide), and either Taxol (paclitaxel) or Taxotere (docetaxel). This treatment course is known as “AC→TH.”
With the chemotherapy drugs Taxotere and Paraplatin (carboplatin). This treatment course is known as “TCH.”
Alone after treatment with multiple other therapies, including an anthracycline (Adriamycin)-based therapy (a type of chemotherapy).
Write a reviewYour Name:
Your Review: Note: HTML is not translated!
Rating: Bad Good
Enter the code in the box below: